The Efficacy of Certolizumab Pegol Over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs
Document Type
Abstract
Publication Date
June 2017
Journal Title
Journal of the American Academy of Dermatology
Department
Dermatology
Recommended Citation
Walsh, J., Gottlieb, A., Hoepken, B., Nurminen, T., & Mease, P. (2017). The Efficacy of Certolizumab Pegol Over 4 Years in Psoriatic Arthritis Patients With and Without Concomitant Use of DMARDs. Journal of the American Academy of Dermatology, 76 (6 Suppl 1), AB253. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/163
COinS
